Transurethral Resection of Bladder Tumor (TURBT)

TURBT, or Transurethral Resection of Bladder Tumor, is a minimally invasive surgical procedure performed via the urethra to remove bladder tumors. It is both a diagnostic and therapeutic intervention, allowing us to remove visible cancer and obtain tissue for pathology to determine stage and grade.

TURBT is the first-line procedure for suspected bladder cancer. It helps determine how deeply the tumor has invaded the bladder wall and whether additional treatments like intravesical therapy (e.g., BCG or Mitomycin C) are needed to prevent recurrence and progression.

• Obtain necessary pre-operative clearances (cardiac or other specialist clearance as indicated).
• Stop blood-thinning medications and supplements as directed (e.g., aspirin, warfarin, Plavix, fish oil).
• Follow fasting (NPO) instructions provided by your surgical team.
• If instructed, complete a Fleet’s enema before arrival.

• Performed under anesthesia in the operating room.
• A resectoscope is inserted through the urethra to visualize and remove tumor tissue.
• Tissue samples are sent to pathology for analysis.
• In some cases, intravesical chemotherapy is instilled immediately afterward.

• You may have a catheter in place for a short period after surgery.
• Blood in the urine and mild discomfort with urination are common for several days.
• Avoid strenuous activity and heavy lifting until cleared by your provider.
• Follow-up appointments are critical for ongoing surveillance.

While TURBT is generally safe, risks include bleeding, bladder perforation, urinary tract infection, and tumor recurrence. Long-term follow-up is essential because bladder cancer has a high recurrence rate.

TURBT provides immediate removal of visible tumors, accurate diagnosis, and staging. It is a key first step in bladder cancer management, often followed by additional therapy to reduce the risk of recurrence and progression.